Sign-On Letters
As a part of our advocacy and awareness efforts, HOPA signs on to joint letters to support legislation, voice concerns, and encourage elected officials to continue supporting and funding optimizing cancer care.
This page features the most recent joint letters and statements HOPA has signed, serving as examples of our collaboration with other organizations on topics of common concern.
Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act
June 25, 2025 - This press release from the CIACC voices its support for the recent reintroduction of the Cancer Drug Parity Act, which would require group and individual health plans to provide coverage for orally-administered and self-injectable anticancer medications at a cost no less favorable than the cost of IV, port-administered, or injected anticancer medications. The release features a quote from HOPA President Robert Mancini, PharmD, BCOP, FHOPA, joining in support of the Cancer Drug Parity Act.
Infectious Diseases Society of America (IDSA) Letter Supporting the Family Vaccine Protection Act
June 13, 2025 - This sign-on letter from the IDSA offers its strong support for the Family Vaccine Protection Act, which would help protect the full scope of the Advisory Committee on Immunization Practices (ACIP).
Modern Medicaid Alliance (MMA) Letter to Senate Leadership on Medicaid Cuts
June 12, 2025 - The linked sign-on letter from MMA and its supporters expresses concerns and opposition to the harmful Medicaid funding cuts proposed in the House reconciliation package, and urges all Senators to reject the provisions.
Research!America Letter on Proposed NIH Cuts
June 5, 2025 - This sign-on letter respectfully requests that Congress reject the proposed NIH budget cuts - totaling $18 billion - in the President's Fiscal Year 2026 (FY26) budget.
American Association of Colleges of Pharmacy (AACP) Statement on Implications of H.R.1 on Pharmacy Education
May 27, 2025 - This sign-on letter from the AACP expresses concerns about substantial negative consequences of H.R.1, the "One Big Beautiful Bill Act," on the pharmacy workforce pipeline - in particular the proposed elimination of the Grad PLUS loan program, limits on federal student loans, and the proposed institutional risk-sharing measures.
Statement of Cancer Organizations Regarding Importance of Medicaid as a Critical Part of the Nation's Cancer Care System
May 6, 2025 - The linked statement from the Cancer Leadership Council (CLC) details the importance of Medicaid to cancer patients and the potential serious adverse effects of the spending cuts currently under consideration.
One Voice Against Cancer (OVAC) Member Sign-On Letter on Funding Requests for Fiscal Year 2026
April 28, 2025 - This sign-on letter from OVAC members requests funding for cancer research and prevention in the Fiscal Year 2026 Labor, Health and Human Services, and Education Appropriations bill.
Cancer Leadership Council Statement on Elimination of the CDC Division of Cancer Prevention and Control
April 25, 2025 - This letter expresses deep concerns about the recommended elimination of the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention (CDC) in 2025.
Coalition for Health Funding (CHF) Sign-On Letter on Fiscal Year 2026 Budget Cuts
April 25, 2025 - This joint letter expresses concern regarding the Administration’s draft Fiscal Year 2026 budget for the Department of Health and Human Services, proposing to cut approximately one-third of its discretionary spending, critically harming the country's research, scientific, and public health infrastructure.
OVAC Sign-On Statement on Recent Executive Actions That Threaten Progress
February 21, 2025 - HOPA is one of 33 organizations who have signed a letter in support of cancer research funding amid Executive Orders that threaten the stability of research infrastructure.
